Find the latest pharmaceutical market place for formulations enquiry about Interferon Beta-1A on PharmaCompass.com.

Various Finished Dosage Formulations needed in Jordan [ENA11573]

A company that deals in the distribution of various pharmaceutical products is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with EU dossiers for each.
1. Methylprednisolone (250 mg) Vials. The required quantity is 55,000 units
2. Octreotide Acetate (20 mg) Vials. The required quantity is 6,000 units.
3. Octreotide (30 mg) Vials. The required quantity is 4,000 units.
4. Bevacizumab (100 mg) Vials. The required quantity is 32,000 units.
5. Peginterferon alfa 2a (180 mcg/ ml) Injections. The required quantity is 2,300 units.
6. Interferon Beta-1a (30 mcg) Vials. The required quantity is 16,000 units.

Reply

06 Oct 2021

Tender// Various Finished Dosage Formulations needed in Poland [ENA10510]

Upper Silesian Medical Center prof. Leszek Giec of the Medical University of Silesia in Katowice is looking for supplies of Various Finished Dosage Formulations. The suppliers must support this tender with ESPD. The deadline is 8-June-2021.
1. Infliximab (100 mg) Injections. The required quantity is 400 units.
2. Interferon Beta-1A (44 mcg/ 0.5 ml x 4 cartridges and 1.5 ml) Cartridge. The required quantity is 240 units.
3. Macitentan (10 mg) Tablets. The required quantity is 380 units.
4. Epoprostenol (0.5 mg and 1.5 mg) Solution for infusion. The required quantity is 30 units and 3,000 units respectively.
5. Interferon Beta-1A (30 mcg/ 0.5 ml) Powder + solvent. The required quantity is 360 units.

Reply

27 May 2021

Tender// Various Finished Dosage Formulations needed in Poland [ENA09441]

University Clinical Hospital in Olsztyn is looking for supplies of Various Finished Dosage Formulations. The suppliers must support this tender with ESPD. The deadline is 4-Feb-2021.
1. Dimethyl Fumarate (120 mg & 240 mg) Hard Gastro-Resistant Capsules in the packaging of 14 capsules and 56 capsules respectively. The required quantity is 4 units and 367 units respectively.
2. Interferon Beta-1A (30 mcg/ 0.5 ml) Solution for Injection in pack of 4 pen. The required quantity is 46 units.
3. Human immunoglobulin, 10% intravenous solution, with an IgG content of 98% and IgA no more than 0.025%, with indications for treatment, among others, CIDP. The required quantity is 860 units.

Reply

08 Jan 2021

Tender// Supply of Medicinal Products for the Treatment of Multiple Sclerosis needed in Poland [ENA09359]

Multidisciplinary City Hospital J. Strusia w Poznaniu is looking for supplies of Various Finished Dosage Formulations. The deadline is 26-Jan-2021.
1. Interferon Beta 1B (250 mcg/ ml) Solution for Injection. The required quantity is 1,050 pack in a multipack containing 15 pcs. Individual units, each containing: 1 vial with powder for solution for injection, 1 pre-filled syringe with 1.2 ml solvent for reconstitution, 1 vial adapter with needle + 2 alcohol swabs.
2. Interferon Beta-1A (30 mcg) Pen. The required quantity is 240 pack in 5 ml x 4 pen packaging.
3. Interferon Beta-1A (44 mcg/ ml) Pre-filled Syringes. The required quantity is 186 pack in [0.44 mg / 05 ml = 12 million IU] x 12 pre-filled syringes or [0.132mcg / 1.5ml = 26 IU] x4 cartridges.
4. Dimethyl Fumarate (0.12 g & 0.24 g) Capsules. The required quantity is 45 pack in 14 capsules packaging and 762 pack in 56 capsules packaging respectively.
5. Teriflunomide (14 mg) Tablets. The required quantity is 240 pack in 28 tablets packaging.
6. Glatiramer Acetate (40 mg) Injections. The required quantity is 375 pack in 12 pre-filled syringes packaging.
7. Fingolimod (0.5 mg) Tablets. The required quantity is 90 pack in 28 pack packaging.
8. Natalizumab (1 mg) Injections. The required quantity is 100 pack in 1 pack.
9. Ocrelizumab (30 mg/ ml & 300 mg/ 10 ml) Solution for Infusion. The required quantity is 2 pack in 1 pack.

Reply

28 Dec 2020